Combined Anti-CD40 and Anti-IL-23 Monoclonal Antibody Therapy Effectively Suppresses Tumor Growth and Metastases
Authorvon Scheidt, Bianca; Leung, Patrick S. K.; Yong, Michelle C. R.; Zhang, Yu; Towne, Jennifer E.; Smyth, Mark J.; Teng, Michele W. L.
Source TitleCANCER RESEARCH
PublisherAMER ASSOC CANCER RESEARCH
AffiliationSir Peter MacCallum Department of Oncology
Document TypeJournal Article
Access StatusThis item is currently not available from this repository
NHMRC Grant codeNHMRC/1021139
Fulltext embargoed for: 12 months post date of publication
Tumor-induced immunosuppression remains one of the major obstacles to many potentially effective cancer therapies and vaccines. Host interleukin (IL)-23 suppresses the immune response during tumor initiation, growth, and metastases, and neutralization of IL-23 causes IL-12-dependent antitumor effects. Here, we report that combining agonistic anti-CD40 monoclonal antibodies (mAb) to drive IL-12 production and anti-IL-23 mAbs to counter the tumor promoting effects of IL-23 has greater antitumor activity than either agent alone. This increased antitumor efficacy was observed in several experimental and spontaneous lung metastases models as well as in models of de novo carcinogenesis. The combination effects were dependent on host IL-12, perforin, IFN-gamma, natural killer, and/or T cells and independent of host B cells and IFN-alpha beta sensitivity. Interestingly, in the experimental lung metastases tumor models, we observed that intracellular IL-23 production was specifically restricted to MHC-II(hi)CD11c(+)CD11b(+) cells. Furthermore, an increase in proportion of these IL-23-producing cells was detected only in tumor models where IL-23 neutralization was therapeutic. Overall, these data suggest the clinical potential of using anti-CD40 (push) and anti-IL-23 mAbs (pull) to tip the IL-12/23 balance in established tumors.
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References